Final Long-Term Results on Landmark Clinical Study Showing Modified Citrus Pectin Successfully Treats Biochemically Relapsed Prostate Cancer ...Middle East

SANTA ROSA, Calif., Feb. 16, 2023 /PRNewswire/ -- Better Health Publishing — Results from an 18 month phase II clinical trial on the benefits of dietary supplement modified citrus pectin in biochemically relapsed prostate cancer will be presented at the American Society for Clinical...

Hence then, the article about final long term results on landmark clinical study showing modified citrus pectin successfully treats biochemically relapsed prostate cancer was published today ( Friday 17/02/2023 - 01:13 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Final Long-Term Results on Landmark Clinical Study Showing Modified Citrus Pectin Successfully Treats Biochemically Relapsed Prostate Cancer )

Also on site :

• UK ‘runs out’ of warships – leaving Germany to take over key Nato mission
• Kim Jong Un uses Iran war to justify North Korea’s decision to keep its nuclear weapons
• AI robots could cost $13,000 by 2035: Here’s what that means for CFOs